These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9605123)

  • 1. Two T cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages.
    Delvig AA; Robinson JH
    J Immunol; 1998 Jun; 160(11):5267-72. PubMed ID: 9605123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes.
    von Delwig A; Ramachandra L; Harding CV; Robinson JH
    Eur J Immunol; 2003 Sep; 33(9):2353-60. PubMed ID: 12938211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of viable group A streptococci leads to major histocompatibility complex class II presentation of T cell epitopes from the major protective antigen.
    Rossiter BA; Alfonso C; Kehoe MA; Robinson JH
    Eur J Immunol; 1994 May; 24(5):1244-7. PubMed ID: 7514136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
    Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
    J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
    Matousek MP; Nedrud JG; Harding CV
    J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC).
    Musson JA; Hayward RD; Delvig AA; Hormaeche CE; Koronakis V; Robinson JH
    Eur J Immunol; 2002 Sep; 32(9):2664-71. PubMed ID: 12207351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms.
    Griffin JP; Chu R; Harding CV
    J Immunol; 1997 Feb; 158(4):1523-32. PubMed ID: 9029086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calcium homeostasis and flux during bacterial antigen processing in murine macrophages.
    Delvig AA; Robinson JH
    Eur J Immunol; 1999 Aug; 29(8):2414-9. PubMed ID: 10458754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The route of bacterial uptake by macrophages influences the repertoire of epitopes presented to CD4 T cells.
    von Delwig A; Bailey E; Gibbs DM; Robinson JH
    Eur J Immunol; 2002 Dec; 32(12):3714-9. PubMed ID: 12516565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes.
    Pfeifer JD; Wick MJ; Russell DG; Normark SJ; Harding CV
    J Immunol; 1992 Oct; 149(8):2576-84. PubMed ID: 1383320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
    Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
    J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodominance does not result from peptide competition for MHC class II presentation.
    Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
    J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
    Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
    J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.